Phenotypic and genotypic characteristics of mastocytosis according to the age of onset

PLoS ONE

Volumn 3, Issue 4, 2008, Pages

  Lanternier, Fanny ^a   Cohen Akenine, Annick ^b   Palmerini, Fabienne ^c,d,e   Feger, Frédéric ^f   Yang, Ying ^c,d,e   Zermati, Yael ^k   Barète, Stéphane ^g   Sans, Beatrix ^h   Baude, Cédric ^b   Ghez, David ^a   Suarez, Felipe ^a   Delarue, Richard ^a   Casassus, Philippe ⁱ   Bodemer, Christine ^a   Catteau, Adeline ^b   Soppelsa, Frédérique ^b   Hanssens, Katia ^b   Arock, Michel ^f   Sobol, Hagay ^d   Fraitag, Sylvie ^j   Canioni, Danièle ^j   Moussy, Alain ^b   Launay, Jean Marie ^k   Dubreuil, Patrice ^c,d,e   Hermine, Olivier ^a,f   Lortholary, Olivier ^a   more..

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b AFIRMM   (France)

^c INSERM   (France)

^d INSTITUT PAOLI CALMETTES   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f CNRS   (France)

^g HÔPITAL TENON   (France)

^h CHU PURPAN   (France)

ⁱ AVICENNE HOSPITAL   (France)

^j HÔPITAL NECKER ENFANTS MALADES   (France)

^k HÔPITAL LARIBOISIÈRE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; CUTANEOUS MASTOCYTOSIS; EXON; FEMALE; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC TRAIT; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MASTOCYTOSIS; ONSET AGE; PATHOGENESIS; PHENOTYPE; PROSPECTIVE STUDY; SCHOOL CHILD; SKIN BIOPSY; SYSTEMIC MASTOCYTOSIS; BIOPSY; CHILD; DISEASE COURSE; GENETICS; MIDDLE AGED; MUTATION; PATHOLOGY; SKIN;

ADULT; AGE OF ONSET; BIOPSY; CHILD; DISEASE PROGRESSION; FEMALE; GENOTYPE; HUMANS; MALE; MASTOCYTOSIS; MIDDLE AGED; MUTATION; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-KIT; SKIN;

EID: 44849118922     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001906     Document Type: Article

References (22)

1. Valent P, Akin C, Sperr WR, et al. (2003) Diagnosis and treatment of systemic mastocytosis: state of the art. Br J Haematol 122: 695-717.
2. Hartmann K, Metcalfe DD (2000) Pediatric mastocytosis. Hematol Oncol Clin North Am 14: 625-640.
3. Azana JM, Torrelo A, Mediero IG, Zambrano A (1994) Urticaria pigmentosa: a review of 67 pediatric cases. Pediatr Dermatol 11: 102-106.
4. Iemura A, Tsai M, Ando A, Wershil BK, Galli SJ (1994) The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 144: 321-328.
5. Mekori YA, Oh CK, Metcalfe DD (1993) IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J Immunol 151: 3775-3784.
6. Furitsu T, Tsujimura T, Tono T, et al. (1993) Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 92: 1736-1744.
7. Worobec AS, Semere T, Nagata H, Metcalfe DD (1998) Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis. Cancer 83: 2120-2129.
8. Nagata H, Worobec AS, Oh CK, et al. (1995) Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci U S A 92: 10560-10564.
9. Longley BJ Jr., Metcalfe DD, Tharp M, et al. (1999) Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci U S A 96: 1609-1614.
10. Buttner C, Henz BM, Welker P, Sepp NT, Grabbe J (1998) Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior. J Invest Dermatol 111: 1227-1231.
11. Escribano L, Orfao A, Diaz-Agustin B, et al. (1998) Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood 91: 2731-2736.
12. Yanagihori H, Oyama N, Nakamura K, Kaneko F (2005) c-kit Mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation. J Mol Diagn 7: 252-257.
13. Valent P, Horny HP, Escribano L, et al. (2001) Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 25: 603-625.
14. Fraitag-Spinner S (2007) [Cutaneous mastocytosis]. Ann Dermatol Venereol 134: 589-592.
15. Horny HP, Valent P (2001) Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings. Leuk Res 25: 543-551.
16. Middelkamp Hup MA, Heide R, Tank B, Mulder PG, Oranje AP (2002) Comparison of mastocytosis with onset in children and adults. J Eur Acad Dermatol Vernereol 16: 115-120.
17. Fearfield LA, Francis N, Henry K, Costello C, Bunker CB (2001) Bone marrow involvement in cutaneous mastocytosis. Br J Dermatol 144: 561-566.
18. Czarnetzki BM, Kolde G, Schoemann A, Urbanitz S, Urbanitz D (1998) Bone marrow findings in adult patients with urticaria pigmentosa. J Am Acad Dermatol 18: 45-51.
19. Rodermund OE, Hauser W, Burkhardt R, Grips KH, Stein G (1978) [Bone marrow changes in mastocytosis]. Dermatol Monatsschr 1978, 164: 493-496.
20. Garcia-Montero AC, Jara-Acevedo M, Teodosio C, et al. (2006) KIT mutation in mast cells and other bone marrow haematopoietic cell lineages in systemic mast cell disorders. A prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 2006.
21. Hartmann K, Wardelmann E, Ma Y, et al. (2005) Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis. Gastroenterology 2005, 129: 1042-1046.
22. Zhang LY, Smith ML, Schultheis B, et al. (2006) A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapy. Leuk Res 2006, 30: 373-378.